Development of an automated cartridge-based breast cancer detection assay- an academic-industrial partnership
Active Project Grant Awarded Last action
- Award ID
- R01CA269237
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,799,957
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date 88% complete
- Place of performance
- Baltimore, MD 21205, USA
Award details come from USAspending.gov.
Description
- Abstract
- In many low- and middle-income countries (lmics) breast cancer is diagnosed at advanced stages. Many women present with a palpable breast mass, which is rare in communities where breast screening is available. In addition to limited imaging facilities, prolonged diagnostic delays (76-630 days) due in part to the extreme shortage of pathologists (as few as 1 per million/population) contribute to a 5-year mortality rate up to 4 times higher than that in the US. An innovative solution to this problem could be an affordable, easily deployable molecular test to identify and prioritize women likely to have a malignancy for expedited biopsy and pathology review. IT is well established that early detection of breast cancer improves survival. With our industrial partner, cepheid, we propose to build on our published breast cancer detection prototype to develop an affordable,
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $65,835 | |
| Amendment | $501,255 | |
| Amendment | $501,255 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $102,410 | |
| Amendment | $102,410 | |
| Amendment | $85,921 | |
| Amendment | $85,921 | |
| Amendment | $457,143 | |
| Amendment | $457,143 | |
| Amendment | $0 | |
| Amendment | $79,170 | |
| Amendment | $533,346 | |
| Amendment | $533,346 | |
| Amendment | $551,956 | |
| Amendment | $551,956 | |
| Amendment | $595,445 | |
| Original award | $595,445 |
Show all 20
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Wits Health Consortium (Pty) LTD | $168,245 | |
| Cepheid | $499,046 | |
| Wits Health Consortium (Pty) LTD | $210,929 |
Quick answers
Who received award R01CA269237?
R01CA269237 was awarded to The Johns Hopkins University by National Cancer Institute (National Institutes of Health) on July 11, 2022.
How much is award R01CA269237 worth?
$5,799,957 has been obligated on R01CA269237.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award